Meloxicam Bluefish

Meloxicam, the active ingredient in Meloxicam Bluefish, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It is indicated for the management of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute pain in adult patients.

GNH USA supplies Meloxicam Bluefish as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam is an NSAID that reduces inflammation and pain in several musculoskeletal disorders.

- Osteoarthritis: alleviates joint pain and improves functional mobility. - Rheumatoid arthritis: decreases synovial inflammation and slows disease‑related joint damage. - Ankylosing spondylitis: reduces spinal stiffness and chronic back pain. - Acute pain: provides rapid relief of moderate to severe pain from injury or surgery.

Meloxicam may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Gastro‑intestinal discomfort or dyspepsia. - Headache. - Dizziness. - Peripheral edema. - Elevated blood pressure. - Skin rash or pruritus.

Serious or Rare Side Effects: - Gastro‑intestinal ulceration or bleeding. - Cardiovascular events such as myocardial infarction or stroke. - Hepatic injury with elevated liver enzymes. - Renal impairment or failure. - Severe skin reactions (e.g., Stevens‑Johnson syndrome). - Anaphylactic or severe hypersensitivity reactions.

Before initiating therapy, clinicians should consider several safety measures.

- Assess gastrointestinal risk: evaluate history of ulcers or bleeding. - Monitor cardiovascular status: watch for hypertension or thrombotic events. - Evaluate renal and hepatic function: adjust use in impairment. - Use the lowest effective dose for the shortest duration needed. - Avoid in patients with known hypersensitivity to meloxicam or other NSAIDs. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Meloxicam can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Warfarin or other anticoagulants: increased bleeding risk. - ACE inhibitors or ARBs: potential for reduced renal function. - Lithium: elevated lithium serum concentrations.

Moderate Interactions (Monitor Closely): - Diuretics: possible decrease in renal clearance. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency. - Concomitant NSAIDs or corticosteroids: additive gastrointestinal toxicity.